Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 2005

View Archived Issues

Drug discovery targets for atherosclerosis

BPC-157 enhances healing during CO2 laser therapy

ADHD treatment consistency varies with methylphenidate formulations

Candesartan reduces new-onset diabetes in heart failure patients

Transdermal 4-hydroxytamoxifen demonstrates activity in breast cancer patients

Adenoviral interferon beta delivery feasible for pleural malignancies

Gene therapy with IL-10 ameliorates atherogenesis in mice

PPARalpha/delta agonists show beneficial effects on HDL-C in primates

Purdue Pharma suspends Palladone Capsules

Ortec to begin confirmatory OrCel trial

Updated labeling for Cialis, Levitra and Viagra

Brazilian patients receive Zilver PTX paclitaxel-coated stent for PAD

Xoma to terminate BPI agreement with Zephyr Sciences

Approvable letter for Pulminiq

Adherex enters into licensing deal with GlaxoSmithKline

ChemGenex plans registration-directed trials for Ceflatonin

Genaissance enters into HAP Technology agreement with Organon

Nautilus advances improved IFN-beta into preclinical development

MacroGenics signs agreement for anti-CD3 antibody for type 1 diabetes

Active Biotech's 57-57 successfully completes first clinical study

Antitumor efficacy reported for yttrium-90 microspheres

Sankyo to resume development of CS-917

Good safety and pharmacokinetic profile of XP-19986 in healthy volunteers

Rexin-G enters phase I study for pancreatic cancer

Recent patents describe novel antibacterial agents

LG Life Sciences claims new agents for acute hepatitis, liver cirrhosis and rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...